The electrophysiologic efects of amiodarone were examined in 13 dogs that received 30 g amiodarone orally during 3 weeks and compared with 13 control dogs that did not receive amiodarone. Longitudinal and transverse epicardial conduction velocities were estimated with a square array of 64 closely spaced electrodes and a computer-assisted acquisition and analysis system. Amiodarone caused a rate-dependent decrease in conduction velocity with a slightly greater effect in the longitudinal direction of propagation. Rate-related depression of conduction velocity developed rapidly after abrupt shortening of the pacing cycle length; 67% of the change occurred between the first two beats of the rapid train, and little change occurred after the 10th beat. Recovery from use-dependent depression of conduction velocity was exponential with a mean time constant of 447±+172 msec in the longitudinal direction and 452±265 msec in the transverse direction. Repolarization intervals, defined as the interval between the activation time and the repolarization time in the unipolar electrograms, correlated highly with refractory period determinations in the absence and presence of amiodarone at each cycle length tested. The increase in repolarization intervals and refractory periods resulting from amiodarone treatment did not vary with cycle length. Amiodarone treatment also resulted in a significant rate-related reduction in systolic blood pressure. The systolic blood pressure in the group that received amiodarone decreased by a mean of 50±23% between steady-state pacing cycle lengths of 1,000 and 200 msec, whereas the corresponding decrease in the control group was 21±32% (p < 0.05). Plasma and myocardial amiodarone and desethylamiodarone levels were comparable to those observed clinically. We conclude that long-term amiodarone administration causes rate-dependent reductions in conduction velocity and blood pressure and causes rateindependent increases in repolarization intervals. (Circulation 1989;79:948-958) Amiodarone is an effective, widely used antiarrhythmic drug.1 Reduction of conduction velocity may be an important antiarrhythmic effect of amiodarone. Previous investigations showed that amiodarone decreases sodium current,2 reduces the maximum upstroke velocity of the action potential (VmX)3-6 and prolongs QRS duration,7-9 but its effects on myocardial conduction velocity have not been reported. 
The electrophysiologic efects of amiodarone were examined in 13 dogs that received 30 g amiodarone orally during 3 weeks and compared with 13 control dogs that did not receive amiodarone. Longitudinal and transverse epicardial conduction velocities were estimated with a square array of 64 closely spaced electrodes and a computer-assisted acquisition and analysis system. Amiodarone caused a rate-dependent decrease in conduction velocity with a slightly greater effect in the longitudinal direction of propagation. Rate-related depression of conduction velocity developed rapidly after abrupt shortening of the pacing cycle length; 67% of the change occurred between the first two beats of the rapid train, and little change occurred after the 10th beat. Recovery from use-dependent depression of conduction velocity was exponential with a mean time constant of 447±+172 msec in the longitudinal direction and 452±265 msec in the transverse direction. Repolarization intervals, defined as the interval between the activation time and the repolarization time in the unipolar electrograms, correlated highly with refractory period determinations in the absence and presence of amiodarone at each cycle length tested. The increase in repolarization intervals and refractory periods resulting from amiodarone treatment did not vary with cycle length. Amiodarone treatment also resulted in a significant rate-related reduction in systolic blood pressure. The systolic blood pressure in the group that received amiodarone decreased by a mean of 50±23% between steady-state pacing cycle lengths of 1,000 and 200 msec, whereas the corresponding decrease in the control group was 21±32% (p < 0.05). Plasma and myocardial amiodarone and desethylamiodarone levels were comparable to those observed clinically. We conclude that long-term amiodarone administration causes rate-dependent reductions in conduction velocity and blood pressure and causes rateindependent increases in repolarization intervals. (Circulation 1989; 79:948-958) Amiodarone is an effective, widely used antiarrhythmic drug.1 Reduction of conduction velocity may be an important antiarrhythmic effect of amiodarone. Previous investigations showed that amiodarone decreases sodium current,2 reduces the maximum upstroke velocity of the action potential (VmX)3-6 and prolongs QRS duration,7-9 but its effects on myocardial conduction velocity have not been reported. Amiodarone's effect on sodium current2 and Vmax3-6 are use dependent,2 6 but discrepancies exist in the reported rates of development of use-dependent block. Mason et a13 delivered trains of impulses at a cycle length of 300 msec to guinea pig papillary muscles treated with amiodarone, and they found that 80% of the change in Vmax developed between the first two impulses but that a steady-state Vmax was probably not reached after 19 impulses. In contrast, using a similar stimulation protocol, Varro et a15 noted that steady-state block was reached after an average of only 4.2 stimuli, and Follmer et a12 found that steady-state block of sodium current was obtained by the second pulse with an interstimulus interval of 500 msec. Discrepancies also have been reported in the rates of recovery from block, with recovery time constants ranging from 282 to 1,600 msec.235 These indexes of rate-dependent effects on sodium channel block are of more than theoretical interest because they reflect the heart rates at which conduction velocity depression devel-ops and are characteristic for a particular antiarrhythmic drug.
To complicate matters further, drug-related changes observed at the cellular level may not perfectly mirror events in intact tissue. Time constants of recovery from drug-induced conduction velocity depression observed in vivo tend to be shorter than their in vitro counterparts.10 Moreover, myocardial conduction is anisotropic, it is faster in the direction parallel to fiber orientation and slower in the direction transverse to fiber axes.1" Theoretical and experimental evidence exists that the effects of sodium channel blocking agents on conduction velocity are also anisotropic, having proportionally greater depressant effects on longitudinal conduction velocity.12,13 The primary purpose of this investigation was to measure the rate-dependent effects of long-term amiodarone administration on longitudinal and transverse conduction velocity in canine left ventricular myocardium in vivo.
Alteration of repolarization is another important property of antiarrhythmic drugs. Although amiodarone is known to prolong action potential duration and refractoriness, little information exists regarding the effects of heart rate on these actions. Therefore, we determined the effects of rate on myocardial repolarization in dogs treated with longterm administration of amiodarone in doses sufficient to cause reduction of conduction velocity.
Because of their potential clinical significance, we also examined the effects of long-term amiodarone administration on normal automaticity, stimulation threshold current, and blood pressure.
Methods

Animal Preparation
Thirteen adult mongrel dogs of either sex (15-30 kg) received amiodarone 2 g/day orally, 5 days a week for 3 weeks. This dose is equivalent to the cumulative per kilogram dose that patients with severe ventricular arrhythmias receive after 6 months of treatment according to a recommended schedule.'4 Thirteen other dogs served as controls. The animals were anesthetized with an intravenous bolus of sodium pentobarbital 30 mg/kg followed by a constant intravenous infusion of 0.03 mg/kg/min. They were then intubated and ventilated with a Harvard respirator (South Natick, Massachusetts). Arterial blood gases were obtained every 30 minutes, and pH was maintained between 7.35 and 7.45 by altering the rate and depth ofventilation. Catheters were inserted into the right femoral artery and both femoral veins for continuous arterial blood pressure monitoring, blood sampling, and drug infusion. Normal saline was continuously infused at 1 ml/kg/hr.
The heart was exposed through a median sternotomy and cradled in the pericardium. Care was taken to minimize blood loss. A quadripolar electrode plaque was sewn to the right ventricle. Formalin was injected into the atrioventricular conduction system by a previously described method to interrupt atrioventricular conduction. 15 An epoxy plaque with 64 flat unipolar silver electrodes (0.6-mm diameter) in an 8 by 8 array with 2-mm interelectrode distance was sewn to the left ventricle near the left anterior descending artery one third of the distance from apex to base. The unipolar electrodes were referenced to a Wilson central terminal. A flat thermistor was placed facing the left ventricular epicardium near the electrode plaque to monitor epicardial temperature. The pericardial cradle was then taken down, and the chest wall apposed and covered.
Shortly after the animal was anesthetized, a baseline rectal temperature was obtained. After the chest was closed, the ventricles were paced at 120 beats/min for 30 minutes while the core temperature returned to baseline with the aid of a thermal blanket. Pacing maneuvers and measurements were then performed. Rectal and cardiac temperatures were maintained within 0.50 C of the baseline rectal temperature throughout the experiment. These experiments conformed to the guiding principles of the American Physiological Society, and the experimental protocol was approved by the University of Utah Internal Animal Care Use Committee.
Analysis System
The input circuitry of the data acquisition and analysis system consisted of 64 differential amplifiers (input impedance greater than 1012 fQ), each with sample and hold outputs. Electrograms were recorded at a band width of 0.03 to 500 Hz, sampled at a 1 kHz rate, multiplexed into a programmable-gain amplifier by four 16:1 multiplexers, and digitized by a 12-bit analog-to-digital converter. The digital output of the converter was sequentially multiplexed through a saturation detection circuit and into a first in-first out memory that permitted asynchronous buffering between the intermittent bursts of sampled data and the random access memory. The computer (MicroVAX II, Digital Electric, Maynard, Massachusetts) acquired the data through an optically isolated interface and then stored the data on a fixed disk. The data were transferred from the hard disk to high-speed digital magnetic tape for subsequent analysis. A smoothing procedure with parabolic leastsquares fit was used to minimize effects of noise. 16 (Figure 1 ). Rapid (longitudinal) and slow (transverse) directions of propagation were clearly discernible from the maps. A line was drawn from the pacing site to the outer edge of the map perpendicular to the most widely spaced isochrones ( Figure  1 ). Longitudinal conduction velocity was calculated between two electrode sites collinear with this line by dividing the distance between them by the difference of their activation times. A second line, perpendicular to the first, was drawn through the densely spaced isochrones, and transverse conduction velocity was computed between two electrode sites collinear with the second line. For consistency, the isochrone map used to select electrodes for determining conduction velocities was constructed from data obtained during pacing at a cycle length of 500 msec. However, when isochrone maps from all pacing cycle lengths used in a given experiment were compared, the directions of maximum and minimum propagation did not differ despite rate-related changes in conduction velocities. The mean (± SD) distances between the pair of electrodes used to compute conduction velocity in the longitudinal and transverse directions were 10.3 ± 2.5 and 6.2± 1.6 mm, respectively, in the group that received amiodarone, and the distances were 9.8 ± 1.0 and 6.7 ± 1.1 mm, respectively, in the control group. No significant differences were found between the two groups concerning the distances over which conduction velocities were computed. The calculation of conduction velocity as we have defined it presumes that the path of propagation is direct and in the superficial epicardial layer. This cannot be proved without knowledge of activation in three dimensions. However, we carefully reviewed electrode sites for evidence of indirect propagation, which can sometimes be identified by the presence of sudden changes in the density of isochrone lines. This is most likely to occur in the transverse direction where more rapid conduction in a subepicardial layer can "preexcite" distal tissue before it is activated by the wave of excitation in the superficial tissue. Electrode site selections were adjusted to avoid such areas. For this reason, the distances between the electrodes used to compute transverse conduction velocities were shorter than those used for longitudinal conduction velocities.
The rate-dependent effects of amiodarone on conduction velocity were assessed during fixed-rate pacing at cycle lengths of 1,000, 500, 300, 250, and 200 msec. Measurements were obtained after 3 minutes of pacing at each cycle length except 200 msec, which was performed for 1 minute to avoid prolonged hypotension. Development of druginduced rate-related conduction velocity depression was assessed by abruptly decreasing the pacing cycle length from 1,000 to 300 msec and by measuring the conduction velocities of the first 10 beats and the 600th beat of the shorter cycle length.
Recovery of conduction velocity from ratedependent depression was examined by determining the conduction velocity of the beat after a test stimulus (S2) delivered with a variable coupling interval to the last beat of a 3-minute pacing train of cycle length 300 msec. Conduction velocity data were normalized and converted to an index of fractional depression by the equation: (Omax -0test)/Omx Omax is the conduction velocity of test stimulus delivered after the longest pause obtainable, and Otest is the conduction velocity of the test impulse. To avoid the possible influence of voltage-dependent eflects on conduction velocity resulting from incomplete repolarization, only test intervals 30 msec greater than the eflective refractory period were used. Plots of the fractional conduction velocity versus time were fit to a monoexponential function with a nonlinear leastsquares parameter fitting program.19
Repolarization Intervals and Refractory Periods
For each experiment, two electrode sites on the plaque were chosen from which refractory periods and repolarization intervals were determined. One site was in the longitudinal direction of propagation, the other in the transverse path ( Figure 1 ). The electrodes were chosen in an area of relatively uniform propagation to avoid acceleration and deceleration effects on repolarization. 20 The repolarization time was defined as the time of maximum first derivative of the potential of the T wave of the local electrogram as previously described.16 This corresponds to the time of maximum rate of change of voltage during phase 3 of the action potential. 17 The temporal correspondence between repolarization time as measured from electrograms and repolarization measured from action potentials has been shown by simultaneous measurements of intracellular and extracellular potentials.17,2' The repolarization interval for an electrode site was defined as the difference between the repolarization time and the activation time obtained at that site. Repolarization intervals and conduction velocities were obtained for the same beat during fixed-rate pacing, that is, after 3 minutes of pacing at cycle lengths of 1,000, 500, 300, and 250 msec and after 1 minute at a cycle length of 200 msec. Refractory period measurements were performed at cycle lengths of 1,000, 500, and 300 msec as follows: Fixedrate pacing was continued without pause from the original pacing site (Si) after the 3-minute data acquisition, whereas single extrastimuli from the second site (S2) were delivered after every fourth S1. The current of S2 was set to twice the diastolic stimulation threshold current. To minimize perturbation of the pacing rate, the initial S1-S2 interval was set well within the refractory period and was increased by 1-msec intervals until a propagated response occurred.
The S1-S2 interval was then decreased by 10 msec, and the process was repeated twice. If the disparity of the three S1-S2 intervals that just captured the ventricles was greater than 2 msec (less than 1% of determinations), then five determinations were obtained. The refractory period of the S2 site was defined as the mean S1-S2 interval that produced a propagated response minus the activation time at that site. Stimulation Threshold Current Stimulation threshold current was measured at each cycle length (1,000, 500, 300, 250, and 200 msec). Pacing was initiated at a current of 0.1 mA and then reduced in 0.01 mA intervals until oneto-one capture was lost. The lowest current resulting in one-to-one capture was defined as the stimulation threshold at a given cycle length. This method of stimulation did not result in injury currents or local T wave changes. 22 The output of the current source was verified by displaying the voltage drop across a calibrated resistor on a Tektronix 7326 oscilloscope (Beaverton, Oregon) and found to be within 5% of the indicated value.
Automaticity
One hour after the production of complete atrioventricular block, external ventricular pacing was terminated, and the native rhythm was allowed to continue for 1 minute. The mean PP and RR intervals of the last 15 seconds of the native rhythm were defined as the sinus and escape cycle lengths, respectively.
Blood Pressure
Blood pressures were measured from a large-bore catheter (1.0 mm i.d.) placed in the femoral artery connected to a Gould-Statham P23 transducer (Cleveland, Ohio) with a short (6 in.) stiff arterial tube. Signals from the pressure transducer were amplified by a Gould pressure processor and recorded on a Gould ES1000 electrostatic recorder. Systolic and diastolic pressures were obtained after 3 minutes at each pacing cycle length (1 minute at cycle length of 200 msec). The mean of 10 beats was used for each pressure.
Histology
Upon termination of the pacing maneuvers, the animal was killed, and the position of the electrode plaque was marked with sutures. The heart was removed and fixed in a buffered solution of 4% formaldehyde for at least 1 week. The tissue beneath the electrode plaque was excised, and the edge corresponding to the first column of electrodes was marked with India ink. The tissue was embedded in paraffin, sectioned parallel to the epicardial plane, and stained with hematoxylin and eosin. The angle between the myocardial fiber axes of the most superficial layer and a line perpendicular to the marked edge was estimated. This was compared with the angle between the two electrodes used for calculating longitudinal conduction velocity and a line perpendicular to the first column of electrodes. The mean difference between these two angles was 4.9 ± 3.4°in the group that received amiodarone and was 11.9±10.30 in the control group; the differences were not significant. The small differences between these angles indicates that the method of determining the longitudinal direction of propagation described above reflects histologically determined fiber orientation.
Serum and Myocardial Amiodarone Concentration
In the animals that received amiodarone, a sample of blood was withdrawn into a heparinized tube shortly after insertion of the arterial catheter. The sample was centrifuged at 100 C, and the serum was removed and frozen. reported high-pressure liquid chromatographic procedure. 23 To aliquots of plasma (0.5 ml) 0.5 ,ug internal standard (L8040) and 2 ml phosphate buffer (pH 5.4) were added. This was then extracted twice with 5 ml hexane. The aqueous phase was discarded, and the pooled organic phases were evaporated to dryness at 350 C under nitrogen. The residue was then redissolved in 0.1 ml methanol, and an aliquot (20-50 gl) was injected onto the column. The 2 ml aliquot resulting from tissue homogenation was evaporated to dryness, and the residue was redissolved in 2 ml phosphate buffer (pH 5.4) and extracted in the same manner as described for plasma. Based on peak height comparisons with nonextracted standards, amiodarone and desethylamiodarone were extracted better than 85% from plasma and myocardium.
Statistical Analysis
Two-tailed Student's t tests for independent samples were used to compare values between the treated and untreated animals. Paired t tests were used for within-groups comparisons. Analysis of variance was used to assess the differences between treated and untreated groups when repeated measures at different cycle lengths were used. Analysis of covariance was used to determine the significance of the difference between refractory periods and repolarization intervals. Data are mean ± SD.
Results
Rate-Dependent Effects on Conduction Velocity
The effects of fixed-cycle length pacing were compared in 13 dogs that received amiodarone and in 13 controls that did not receive amiodarone (Figure 2 ). Longitudinal and transverse conduction velocities did not vary significantly with cycle length in the control dogs. In contrast, animals that received amiodarone showed a significant rate-dependent reduction of both longitudinal and transverse conduction velocities. The mean longitudinal conduction velocity during a cycle length of 1,000 msec in the dogs that received amiodarone (0.61 ± 0.02 m/ sec) was significantly lower than the value obtained in control animals (0.68 ± 0.09 m/sec, p = 0.02), indicating some drug-induced slowing of longitudinal conduction at the longest cycle length. The percent decreases in longitudinal and transverse conduction velocities are shown in Figure 3 . The percent change of conduction velocity was consistently greater in the longitudinal direction, but the differences were not statistically significant (p > 0.1 by ANOVA).
Development of Conduction Velocity Depression
In six control animals, conduction velocity did not vary for the first 10 beats when the pacing cycle length was abruptly decreased from 1,000 to 300 msec but decreased slightly, 5-8%, by 600 beats. In six animals treated with amiodarone, the longitudinal conduction velocity decreased sharply during the first 10 beats of the rapid train, and 67% of the eventual change occurred between the first and second beats of the rapid train, 27% between the second and 10th beats, and 6% between the 10th and 600th beats (Figure 4 The correlations between repolarization intervals and refractory periods were very high (r=0.99) for both controls and animals treated with amiodarone ( Figure 6 ). The slopes of the regression lines for the two groups of animals were close to unity. The regression line for the group that received amiodarone was shifted slightly, but significantly, to the right of the control line (p <0.001). This shift indicates a slightly longer refractory period for a given repolarization interval in the animals treated with amiodarone. This effect is also reflected in the ratio of refractory period to repolarization interval, which was 0.986±0.027 in the control group and 1.015±0.026 in the amiodarone group (p<0.0001).
Rate-Dependent Effects on Repolarization Interval
Repolarization intervals increased with increasing pacing cycle lengths in the control animals ( Figure 7) . The relation between repolarization interval and cycle length of the animals that received amiodarone paralleled that of the controls, but repolarization intervals remained significantly greater compared with controls at all cycle lengths. On average, the group that received amiodarone showed an increase in repolarization of 17 msec over the control group.
Stimulation Threshold Current
No significant relation was found between pacing cycle length and stimulation threshold current in the control group or in the group that received amiodarone. The mean stimulation threshold in the controls was 0.027±0.011 mA and was 0.024±0.007 in the group treated with amiodarone (p>0.1).
Automaticity
After interruption of atrioventricular conduction, all animals developed a stable escape rhythm with uniform QRS complexes. The sinus cycle length was greater in the group that received amiodarone (524 ± 79 msec) than in the control group (334 ± 35 msec, p<0.0001). The cycle length of ventricular escape rhythm was longer in the treated group (1,626 ± 463 msec) than in the control group (1,168 ± 318 msec, p = 0.02).
Blood Pressure
The animals that received amiodarone showed a significantly greater rate-dependent effect on both systolic and diastolic blood pressures compared with control animals (Figure 8 ).
Plasma and Myocardial Concentrations
The mean plasma amiodarone and desethylamiodarone levels were 3.8±3.2 and 0.38±0. 28 ,ug/ml, respectively. The mean myocardial levels of amiodarone and desethylamiodarone were 104.0±78. Cycle Length (ms) Recovety From Conduction Velocity Depression The time constant of recovery from usedependent conduction velocity depression due to amiodarone was about 450 msec in our preparation. The fact that this value was independent of propagation direction suggests that the kinetics of drug unbinding was isotropic. A recovery time constant of 1,600 msec was obtained in sucrose gap preparations of guinea pig papillary muscles in which Vm, was used as an index of sodium current. 3 The same time constant was observed in preparations perfused with amiodarone and from animals treated with long-term administration.3 However, shorter time constants (285 msec) were observed in another study of guinea pig papillary muscles and in canine Purkinje fibers.5 The discrepancy between these two studies could be attributed, in part, to differences in resting potentials (80-85 mV in the former study,3 >90 mV in the latter5) because lower resting potentials will prolong recovery.3'28 The most precise determinations of recovery time constants are probably obtained from direct measurements of sodium current because the magnitude of change is greater. 29 Follmer et a12 performed such measurements in isolated canine Purkinje cells and feline ventricular myocytes. The relevant time constant of recovery from amiodarone-induced sodium channel block for both preparations was 1,430 msec. However, these measurements were obtained at 200 C, which probably results in an overestimate of two to four times the recovery time constant at 370 C. For instance, the recovery time constant of lidocaine at 360 C is 180 msec,30 whereas at 240 C it is 400-750 msec.3' Effects on Repolarization and Refractoriness Analytic derivations and experimental evidence support the temporal coincidence of the rapid phase of repolarization of the action potential and the maximum first derivative of the extracellular potential of the local T wave. 17 This relation has been found to hold for acute ischemia, a range of heart rates and local temperature changes. A high correlation has been shown between repolarization interval and refractory period in the presence and absence of sympathetic stimulation. 16 In the present study, we showed that the high correlation between repolarization intervals and refractory periods is retained in the presence of amiodarone. Thus, rate-related changes in repolarization intervals precisely paralleled those of refractory periods at the cycle lengths tested.
Previous studies documented that long-term administration of amiodarone markedly prolongs action potential duration and refractory periods."13 '26 However, the effect of cycle length on these variables has been less well studied. Amiodarone increased repolarization interval during steadystate pacing at rates that span the range of typical resting and tachycardiac heart rates. Stimulation Threshold Current Amiodarone had no effect on stimulation threshold, which indicates that it should not increase the energy requirements of artificial pacemakers. Although sodium current blockade can decrease excitability,32 the resolution of our measurements (0.01 mA, ±5%) may not have been sufficient to detect a use-dependent change in threshold current. Another possibility is that amiodarone affects different determinants of excitability in opposite directions. Such an effect has been shown for encainide. 33 One previous study found that amiodarone had no effect on pacing thresholds in dogs. 34 Amiodarone slightly, but significantly, increased the duration of refractory period with respect to repolarization interval, which reflects a decrease in another aspect of excitability. Two previous investigations did not detect a significant increase in the ratio of effective refractory period to action potential duration,25'26 but a trend was noted in one of the studies. 26 The small magnitude of the effect and the larger numbers studied in our investigation may account for the discrepancy. Automaticity Long-term amiodarone administration significantly increased the sinus cycle length in the anesthetized open-chest canine preparation by 57%. Depression of sinus node automaticity has been observed in numerous investigations. 4,8'26 We also observed a 40% increase in the escape rhythm after complete atrioventricular block, a previously unreported observation.
Blood Pressure
We observed a significant decrease in systolic blood pressure with increasing stimulation rates in the animals that received amiodarone, an effect not present in the control group except at the fastest pacing rates. Although the hemodynamic effects of amiodarone have been studied,' its rate-dependent hemodynamic properties have not, to our knowledge, been examined previously. Our experiments were not designed to determine the mechanism of amiodarone's effects on blood pressure, but several known effects could affect blood pressure. Amiodarone is a vasodilator,' and the treated animals had lower systolic and diastolic blood pressures at slow pacing rates, although the differences were not significant. Amiodarone also inhibits adrenergic stimulation.1 This could blunt normal adrenergic influences that maintain blood pressure at faster heart rates. Amiodarone causes use-dependent block of calcium channels in cardiac tissue,35,36 which could cause use-dependent decreases in contractility. 37 The fact that mean systolic blood pressure in the animals treated with amiodarone was slightly lower than in controls at a cycle length of 1,000 msec, but dropped significantly with shorter cycle lengths, is consistent with the reported time constant of recovery from amiodarone-induced block of calcium currents of 1,00 msec.36 Amiodarone also blocks sodium channels in a usedependent fashion. In theory, resultant decreases in intracellular sodium ion activity could increase loss of intracellular calcium ions by the sodium-calcium exchange mechanism, thereby reducing contractility. 38 Whatever the mechanism, rate-dependent hemodynamic effects would be largely undesirable in the clinical setting. The greatest changes were observed at the most rapid pacing rates. Therefore, amiodarone therapy could increase hemodynamic deterioration at a given rate of tachycardia. Moreover, decreases in blood pressure were noted even in the physiologic range of heart rates, that is, from 60 to 120 beats/min. This could result in clinically significant deterioration in a patient with severely compromised heart function.
Plasma and Myocardial Drug Levels
The doses of amiodarone we administered were similar to those that patients with severe ventricular arrhythmias receive during 6 or more months.'4 The plasma and myocardial amiodarone and desethylamiodaronie levels detected in our study were in the same range as those found in patients on long-term amiodarone therapy.38-41 However, the mean plasma amiodarone level in our study was about twice the mean level typically found in humans, and the mean desethylamiodarone level was about half.39-42 Plasma amiodarone and desethylamiodarone levels correlated with myocardial levels and with each other. This probably reflects relative equilibrium between the compartments and between the parent drug and its metabolite.
Previous investigations have supported42 '43 and rejected26 a relation between drug levels and electrophysiologic effects. We found a modest correlation between drug levels and rate-dependent effects on conduction velocity and the rate-related reduction in blood pressure. However, no significant correlation was found between drug levels and repolarization intervals and sinus or escape cycle lengths even though amiodarone significantly prolonged these variables. The lack of correlation with these variables could be due to the large variation between individual animals.43
Limitations
We estimated conduction velocity between two electrodes on the epicardial surface of the left ventricle. The path of propagation between the two electrodes was assumed to be direct, which is an assumption that can be verified only by examining activation in three dimensions. On the other hand, complete knowledge of activation in this small volume would require the insertion of multiple electrodes that could cause injury and disturb activation. Our methods provided detailed two-dimensional knowledge of activation over a small (1.6 cm2) area of myocardium with minimal likelihood of perturbing cellular function or structure. Determination of longitudinal and transverse paths of propagation and the choices of electrode sites were guided by the electrical activation sequence throughout the area. The estimates of longitudinal propagation direction correlated closely with histologic determination of myocardial fiber orientation. Although conduction times rather than conduction velocities could be used to avoid specification of the path of propagation, this alternative would not eliminate the necessity that the path be unchanged between maneuvers and would not change the interpretation of the experimental results. Our control values for longitudinal and transverse conduction velocities were similar to those reported previously.l1013A44
Our experimental model permitted examination of a variety of variables relevant to the use of antiarrhythmic drugs. The unconscious state, the anesthetic used, the thoracotomy, and numerous unknown variables could have affected our results, but a more important limitation is that our model does not reproduce the myocardial disturbances that accompany clinical arrhythmias. On the other hand, the fact that our measurements were obtained in the intact heart strengthens the assumption that similar phenomena occur in the clinical setting.
